You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 21, December 1, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Thrombolysis
 •Neurology
 •Cerebrovascular Disease
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Obesity
 •Cardiovascular System
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Conquering Cardiovascular Disease

Progress and Promise

Claude Lenfant, MD

JAMA. 1999;282:2068-2070.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This issue of THE JOURNAL reflects many of the numerous research and clinical advances that have occurred in the diagnosis, treatment, and prevention of cardiovascular disease and, at the same time, provides a window on many issues that will challenge the cardiovascular research community in the years to come. Clearly, the understanding of cardiovascular disease is progressing rapidly and the resulting scientific opportunities are so abundant that continued progress will bring new benefits to patients.

When the National Heart Institute—now the National Heart, Lung, and Blood Institute—was founded in 1948, the country was suffering from what was then termed the heart attack epidemic. Since that time, considerable progress has been made in the development of effective strategies for treatment and prevention, many of which have been widely applied. As a result, there has been a steady decline in the death rates due to the most common . . . [Full Text of this Article]

Author Affiliation: National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus
Rodondi et al.
ANN INTERN MED 2006;144:475-484.
ABSTRACT | FULL TEXT  

Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations
Martinez-Selles et al.
Eur J Heart Fail 2004;6:219-226.
ABSTRACT | FULL TEXT  

Task Force #4--adherence issues and behavior changes: achieving a long-term solution
Ockene et al.
J Am Coll Cardiol 2002;40:630-640.
FULL TEXT  

CT-Based Assessment of Acute Stroke: CT, CT Angiography, and Xenon-Enhanced CT Cerebral Blood Flow
Kilpatrick et al.
Stroke 2001;32:2543-2549.
ABSTRACT | FULL TEXT  

Coronary Heart Disease in the First 30 Years of the 21st Century: Challenges and Opportunities : The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association
Beller
Circulation 2001;103:2428-2435.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.